Your browser doesn't support javascript.
loading
Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1ß production.
Sousa, Jeremy; Cá, Baltazar; Maceiras, Ana Raquel; Simões-Costa, Luisa; Fonseca, Kaori L; Fernandes, Ana Isabel; Ramos, Angélica; Carvalho, Teresa; Barros, Leandro; Magalhães, Carlos; Chiner-Oms, Álvaro; Machado, Henrique; Veiga, Maria Isabel; Singh, Albel; Pereira, Rui; Amorim, António; Vieira, Jorge; Vieira, Cristina P; Bhatt, Apoorva; Rodrigues, Fernando; Rodrigues, Pedro N S; Gagneux, Sebastien; Castro, António Gil; Guimarães, João Tiago; Bastos, Helder Novais; Osório, Nuno S; Comas, Iñaki; Saraiva, Margarida.
Affiliation
  • Sousa J; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  • Cá B; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Maceiras AR; Doctoral Program in Molecular and Cell Biology, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
  • Simões-Costa L; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  • Fonseca KL; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Fernandes AI; Doctoral Program in Molecular and Cell Biology, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
  • Ramos A; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  • Carvalho T; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Barros L; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  • Magalhães C; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Chiner-Oms Á; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  • Machado H; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Veiga MI; Doctoral Program in Molecular and Cell Biology, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
  • Singh A; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  • Pereira R; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Amorim A; São João Hospital Center & EPIUnit-Institute of Public Health, University of Porto, Porto, Portugal.
  • Vieira J; São João Hospital Center & EPIUnit-Institute of Public Health, University of Porto, Porto, Portugal.
  • Vieira CP; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  • Bhatt A; IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  • Rodrigues F; Life and Health Sciences Research Institute, University of Minho, Braga, Portugal.
  • Rodrigues PNS; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Gagneux S; Biomedicine Institute of Valencia (CSIC), Valencia, Spain.
  • Castro AG; Life and Health Sciences Research Institute, University of Minho, Braga, Portugal.
  • Guimarães JT; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Bastos HN; Life and Health Sciences Research Institute, University of Minho, Braga, Portugal.
  • Osório NS; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Comas I; School of Biosciences and Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Saraiva M; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
Nat Commun ; 11(1): 1949, 2020 04 23.
Article in En | MEDLINE | ID: mdl-32327653
ABSTRACT
Genetic diversity of Mycobacterium tuberculosis affects immune responses and clinical outcomes of tuberculosis (TB). However, how bacterial diversity orchestrates immune responses to direct distinct TB severities is unknown. Here we study 681 patients with pulmonary TB and show that M. tuberculosis isolates from cases with mild disease consistently induce robust cytokine responses in macrophages across multiple donors. By contrast, bacteria from patients with severe TB do not do so. Secretion of IL-1ß is a good surrogate of the differences observed, and thus to classify strains as probable drivers of different TB severities. Furthermore, we demonstrate that M. tuberculosis isolates that induce low levels of IL-1ß production can evade macrophage cytosolic surveillance systems, including cGAS and the inflammasome. Isolates exhibiting this evasion strategy carry candidate mutations, generating sigA recognition boxes or affecting components of the ESX-1 secretion system. Therefore, we provide evidence that M. tuberculosis strains manipulate host-pathogen interactions to drive variable TB severities.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Signal Transduction / Cytosol / Interleukin-1beta / Mycobacterium tuberculosis Type of study: Risk_factors_studies / Screening_studies Limits: Animals / Female / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Pulmonary / Signal Transduction / Cytosol / Interleukin-1beta / Mycobacterium tuberculosis Type of study: Risk_factors_studies / Screening_studies Limits: Animals / Female / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Affiliation country: